Quick context to catch up fast.
The committee unanimously rejected adding GLP-1 weight-loss medication coverage to the 2026 medical renewal, which would have increased the proposed rate from 10.4% to 14.4%. It approved keeping vision, employee assistance, Colonial, and Hartford insurance plans in place, while deferring decisions on dental rates and other medical plan options.
Open the committee coverage hubs tied to this summary.
Was this summary helpful?
Your feedback helps us prioritize what to improve next.
The proposed medical renewal would rise 10.4% without coverage for GLP-1 medications used for weight loss; those medications would remain covered for people diagnosed with diabetes. The committee did not support paying the additional cost to cover GLP-1 drugs for all users. It will review comparisons for the GIC program, higher-deductible options, and possible health reimbursement arrangements at a future meeting. Dental rates will also return for a vote after further review of the self-insured plan's deficit.
Follow the major takeaways from this briefing.
Action items flagged by the community.
No follow-ups have been shared yet. Add one in the community board below.
Details and records from this meeting.
Fresh records from this municipality.
Know who to contact about the decisions that matter.